In a 40‑year‑old woman with elevated dehydroepiandrosterone sulfate (DHEA‑S) and testosterone, what is the appropriate diagnostic work‑up and initial management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Elevated DHEA-S and Testosterone in a 40-Year-Old Woman

In a 40-year-old woman with elevated DHEA-S and testosterone, you must immediately exclude life-threatening androgen-secreting tumors (ovarian or adrenal) before considering PCOS, which remains the most common diagnosis if malignancy is ruled out.

Immediate Diagnostic Algorithm

Step 1: Assess Testosterone Level Severity

The degree of testosterone elevation determines urgency and tumor risk 1:

  • Testosterone >150 ng/dL (>5.2 nmol/L): High suspicion for androgen-secreting tumor—proceed urgently to imaging
  • Testosterone 2× upper limit of normal: Mandatory DHEA-S measurement already done; proceed to Step 2
  • Rapid progression of virilization (deepening voice, clitoromegaly, male-pattern baldness): Tumor until proven otherwise, regardless of absolute values 2, 3

Step 2: Localize the Androgen Source

If DHEA-S >600 µg/dL (>16,000 nmol/L):

  • Suggests adrenal adenoma or carcinoma 4
  • Order abdominal CT scan immediately to visualize adrenal glands
  • Critical caveat: Rare ovarian tumors (steroid cell tumors) can paradoxically elevate DHEA-S despite lacking sulfotransferase 5—do not skip pelvic imaging

If DHEA-S normal or mildly elevated with high testosterone:

  • Suggests ovarian source (hyperthecosis or tumor) 4
  • Order pelvic ultrasound to detect ovarian masses or polycystic morphology

Step 3: Complete the Tumor Exclusion Panel 1

Obtain these tests simultaneously:

  • Pregnancy test (if amenorrheic)
  • Early morning 17-hydroxyprogesterone (follicular phase if cycling): Rules out nonclassic congenital adrenal hyperplasia; >200 ng/dL warrants ACTH stimulation test
  • Prolactin: Excludes hyperprolactinemia mimicking PCOS
  • Free testosterone (if total testosterone borderline): Improves sensitivity when SHBG is altered
  • Clinical assessment for Cushing's syndrome (moon facies, striae, proximal weakness): If present, order 24-hour urinary free cortisol or overnight dexamethasone suppression test

Step 4: Imaging Strategy

Pelvic ultrasound (transvaginal preferred):

  • Detects ovarian masses >2 cm reliably
  • Identifies polycystic ovarian morphology (≥20 follicles per ovary or ovarian volume >10 mL)

Abdominal/pelvic CT with contrast:

  • Required if testosterone >150 ng/dL or DHEA-S >600 µg/dL
  • Visualizes both adrenal glands and ovaries

Critical pitfall: Small androgen-secreting tumors (<2 cm), particularly Leydig cell tumors, may be invisible on imaging 6, 2. If clinical suspicion remains high (rapid virilization, very high testosterone) despite negative imaging, consider:

  • Selective ovarian vein catheterization with androgen sampling (if available) 6
  • Diagnostic laparoscopy with bilateral oophorectomy in postmenopausal women or those not desiring fertility 2

Interpretation After Tumor Exclusion

If imaging and labs exclude tumors, the diagnosis is likely PCOS if the patient has 1:

  • Menstrual irregularity (oligomenorrhea: <8 cycles/year or cycles >35 days) OR
  • Polycystic ovaries on ultrasound

Plus documented hyperandrogenemia (which you already have)

Additional PCOS-Related Assessments

Screen for metabolic complications that affect morbidity and mortality:

  • Fasting glucose and HbA1c: Type 2 diabetes risk
  • Lipid panel: Dyslipidemia common in PCOS 7
  • BMI and waist circumference: Central obesity assessment
  • Blood pressure: Hypertension screening
  • Examine for acanthosis nigricans: Insulin resistance marker

Key Clinical Caveats

  1. The 9% positive predictive value problem 8: Most women with testosterone >250 ng/dL (>8.7 nmol/L) do NOT have tumors (only 9% do), but the one who does faces life-threatening malignancy—you cannot miss this diagnosis.

  2. DHEA-S is not foolproof for adrenal localization: Ovarian steroid cell tumors can produce DHEA-S 5, and conversely, some adrenal tumors produce predominantly testosterone with normal DHEA-S.

  3. Timing matters: Measure testosterone in early morning (8 AM), days 4-10 of menstrual cycle if regularly cycling 1. Random timing increases false positives.

  4. Medication interference 4: Valproic acid raises testosterone; estrogen-containing medications raise SHBG (falsely lowering free testosterone).

  5. Age consideration: At 40 years, this patient is premenopausal. Postmenopausal hyperandrogenism has higher tumor probability and warrants even more aggressive workup 2.

When Diagnosis Remains Unclear

If initial workup is negative but hyperandrogenism persists or progresses 1:

  • Repeat testosterone and free testosterone in a reliable specialty laboratory using LC-MS/MS if available
  • Consider dexamethasone suppression test (0.5 mg every 6 hours × 4 days): Adrenal androgens suppress >70%; ovarian androgens (including tumors) do not 9
  • Measure androstenedione: May be elevated when testosterone is borderline
  • GnRH agonist test: Ovarian androgen production (hyperthecosis) suppresses; tumors do not 4

The bottom line: Tumor exclusion is non-negotiable before labeling this as "just PCOS." The consequences of missing an androgen-secreting malignancy include metastatic disease and death, while the consequences of over-investigating include temporary anxiety and healthcare costs—the risk-benefit calculation strongly favors thorough evaluation.

References

3
Research

Ovarian steroid cell tumor as an example of severe hyperandrogenism in 45-year-old woman.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020

4
Guideline

recommendations for investigation of hyperandrogenism.

Annales d'endocrinologie, 2010

8
Research

Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999

Related Questions

In a 33-year-old woman with an elevated serum testosterone level of 2.6 ng/mL, what are the most likely causes and what should be the next diagnostic step?
In a 48-year-old woman with polycystic ovary syndrome, what does a low‑normal DHEA‑S (dehydroepiandrosterone sulfate) level of 0.581 indicate and what is the appropriate management?
What is the appropriate evaluation and management for a 26‑year‑old woman with an elevated total testosterone level of 72 ng/dL?
In a 26-year-old woman with mildly elevated serum testosterone, normal dehydroepiandrosterone (DHEA), estradiol, follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, and thyroid-stimulating hormone (TSH), who presents with oligomenorrhea (period every 56 days) and a negative pregnancy test, what is the most likely diagnosis and first-line management?
A 28-year-old woman with a two-year history of irregular menses, polycystic-appearing ovaries on ultrasound, and elevated serum testosterone—does she meet criteria for polycystic ovary syndrome (PCOS) and what management recommendations should be pursued?
How should I evaluate and manage a 3‑year‑old boy with chronic daytime urinary frequency, nighttime enuresis requiring multiple diaper changes, intermittent constipation (bowel movements every 2–3 days), no history of urinary tract infection, and normal growth?
What is the recommended management and follow‑up for a patient with abdominal pain and a history of ovarian torsion who now has a right ovarian complex cyst (~3 cm) consistent with an involuting hemorrhagic cyst, an atrophic left ovary, and no free pelvic fluid on transabdominal pelvic ultrasound?
In an 11-year-old female with anxiety, ADHD, and DMDD who is taking Concerta (methylphenidate) 36 mg daily and aripiprazole 2 mg daily with residual aggression, what additional medication can be added to better control aggressive and irritable behavior?
Can casual sexual activity increase oxytocin levels enough to cause stress that could trigger polycystic ovary syndrome (PCOS)?
What are the contraindications to colon hydrotherapy?
In an adult with symptomatic anterior knee pain, lateral patellar tilt >5°, focal chondral lesion of the patellar facet, and failed non‑operative treatment for ≥6 weeks, when is a lateral retinacular release combined with patellar chondroplasty indicated, and what are the contraindications and postoperative management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.